Wolverine Asset Management’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9K Sell
148,924
-5,642
-4% -$521 ﹤0.01% 1418
2025
Q4
$9.27K Sell
154,566
-19,867
-11% -$1.2K ﹤0.01% 1430
2025
Q3
$13.5K Sell
174,433
-31,252
-15% -$2.42K ﹤0.01% 1335
2025
Q2
$16.5K Buy
205,685
+27,183
+15% +$1.9K ﹤0.01% 1333
2025
Q1
$13.4K Buy
178,502
+50,485
+39% +$5.25K ﹤0.01% 1281
2024
Q4
$26.2K Buy
+128,017
New +$5.07K ﹤0.01% 1267

Other funds holding BDMDW

Wolverine Asset Management's BDMDW Position: Q1 2026 in Review

Wolverine Asset Management reduced its Baird Medical Investment Holdings Warrant (BDMDW) stake by 3.7% in Q1 2026, selling an estimated $521 and leaving 148,924 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Wolverine Asset Management first reported a position in BDMDW in Q4 2024 and has held it in 6 quarters since. The position peaked at $26.2K in Q4 2024. 27 funds tracked by Wall St. Rank hold BDMDW as of Q1 2026.

  • Wolverine Asset Management held 148,924 shares of Baird Medical Investment Holdings Warrant worth $11.9K as of Q1 2026.
  • Wolverine Asset Management sold 5,642 Baird Medical Investment Holdings Warrant shares in Q1 2026, an estimated $521.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1418 holding.
  • Wolverine Asset Management first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 6 quarters since.
  • Wolverine Asset Management's Baird Medical Investment Holdings Warrant position peaked at $26.2K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.